Resolvin D1 altered the cytotoxicity of P. gingivalis supernatant on HGFs. Resolvin D1 significantly reduced GRO, marginally reduced MCP-1, and marginally increased TGF-β1 from P. gingivalis-treated HGFs, which could alter the ability of P. gingivalis to induce inflammation.
Aims and objectives: The aim of this study was to assess the influence of periodontal status on quality of life (QoL) with the use of a short version of the Oral Health Impact Profile (OHIP-14) in patients with periodontal disease attending university in Riyadh, Saudi Arabia. Materials and methods: Adult patients diagnosed with periodontal disease and having minimum of 15 teeth or more present was included. Included patients were requested to fill a questionnaire form and undergo a comprehensive clinical periodontal examination. The influence of oral health on patients’ QoL was assessed using the Arabic version of OHIP-14. Results: A total of 25 adults aged between 23 and 80 years with a mean age of 49 years completed the questionnaire. The impact of periodontal disease on patient’s QoL was statistically significant in 2 domains, namely physical pain ( P = .004) and psychological disability ( P = .001). The severity of periodontal disease did not show a negative impact on functional limitation. In general, the total OHIP-14 scores were statistically significant with the number of teeth with pocket depths of 5 mm ( P = .001) and 7 mm ( P = .011). Conclusions: Periodontal destruction has a negative impact on QoL. The use of this index as well as other patient-centered outcome measures has significant implications in periodontology, including treatment planning and evaluation of treatment results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.